Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Significant Accounting Policies (Details Narrative)

v3.20.2
Basis of Presentation and Significant Accounting Policies (Details Narrative)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
USD ($)
Jun. 30, 2019
USD ($)
Jun. 30, 2020
USD ($)
Segment
Jun. 30, 2019
USD ($)
Dec. 31, 2019
USD ($)
Number of operating segment | Segment     1    
Primary operating account balance $ 19,315   $ 19,315   $ 7,418
Cash uninsured amount 50   50    
Goodwill 19,092   19,092   $ 19,092
Impairment in goodwill     $ 46,103  
Collaboration revenue 554 $ 592 1,015 $ 5,670  
Merck Sharp & Dohme Corp [Member]          
Accounts receivable related party 592   $ 592    
Merck Sharp & Dohme Corp [Member] | Customer One [Member] | Customer Concentration Risk [Member] | Revenue and Receivables [Member]          
Revenue and receivable percentage     100.00%    
U.S. Financial Institutions One [Member]          
Cash FDIC insured limits 250   $ 250    
U.S. Financial Institutions Two [Member]          
Cash FDIC insured limits $ 250   $ 250